Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Treatment

NICE Approves Use Of Lenalidomide In Patients With Multiple Myeloma Who Have Received Two Or More Previous Therapies
Around 2000 multiple myeloma sufferers in the UK could have their lives extended by around three months after a decision by The UK National Institute for Health and Clinical Excellence (NICE) to approve lenalidomide in those patients who have received two or more previous therapies-provided that the cost of cycles beyond the 26th cycle of treatment are met by the drug manufacturer. A summary of the NICE decision is published in a Special Report Online First and in the July edition of The Lancet Oncology.
generic viagra online
Global Lupus Experts Gather For Historic Meeting -- Urgent And Unmet Needs Of Individuals With Lupus Dominate Agenda
The Lupus Foundation of America (LFA) convened an Expert Panel June 1-2 to address the urgent and unmet need for the development and approval of new, safe, effective, and tolerable medications for people with lupus. It has been more than 50 years since the U.S. Food and Drug Administration (FDA) approved a new drug specifically to treat lupus. Discussions during the two-day meeting in Washington, DC focused on how to better conduct studies of potential new lupus treatments, including clinical endpoints, diagnostic tools, background medications, and clinical trial design.
News of the day
The White House Announces H1N1 Flu Preparedness Summit
The White House announced that Health and Human Services Secretary Kathleen Sebelius, Homeland Security Secretary Janet Napolitano, Education Secretary Arne Duncan, and Homeland Security Advisor John Brennan will host an all-day H1N1 Flu Preparedness Summit with states to further prepare this nation for the possibility of a more severe outbreak of H1N1 flu. The Summit will be held on July 9, 2009 at the Natcher Conference Center at the National Institutes of Health in Bethesda, Maryland.
Oncology

Global AIDS Coordinator Nominee Goosby Testifies Before Senate Committee

President Obama"s choice for the State Department"s global AIDS coordinator position, Eric Goosby, testified on Tuesday at a confirmation hearing with the Senate Foreign Relations Committee, VOA News reports. Goosby would work to continue PEPFAR"s success, and "says he will emphasize prevention if he is confirmed by the Senate," VOA News writes. Goosby, who is currently CEO of the Pangea Global AIDS Foundation and a professor of clinical medicine at the University of California in San Francisco, said, "My mission if confirmed will be to ensure that PEPFAR continues to be a visionary program, a program that continues to exceed our expectations of what can and should be provided to people in re-poor settings." He added, "Working closely with our global partners, we can help reclaim the lives of millions of people who would otherwise be lost to the infection." Senator Richard Lugar (R-Ind.) said that before PEPFAR began there were around 50,000 people in sub-Saharan Africa who were taking antiretroviral drugs. "Today, three times that many are being treated in Kenya alone," he said, adding that PEPFAR includes prevention programs that aim to halt 12 million new HIV cases. Senator Russ Feingold (D-Wisc.) who chaired the hearing said, "We cannot treat our way out of this pandemic alone. The numbers of infections continue to rise in some countries. We need to continue exploring and investing in new prevention strategies to stem the spread of HIV" (Tate, VOA news, 6/9). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009